Univariable Cox regression analysis revealed that age, history of a malignancy or stroke, not using an ACE-inhibitor/angiotensin-II (AT2) antagonist or aspirin, an impaired LVEF, an MR grade ≥2 and multivessel disease during pPCI were significant predictors for 5‐year all-cause mortality. This evidence concerns the gene ACE and stroke disorder.